163 related articles for article (PubMed ID: 24759732)
1. Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.
Athinarayanan S; Wei R; Zhang M; Bai S; Traber MG; Yates K; Cummings OW; Molleston J; Liu W; Chalasani N
PLoS One; 2014; 9(4):e95366. PubMed ID: 24759732
[TBL] [Abstract][Full Text] [Related]
2. Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.
Bardowell SA; Stec DE; Parker RS
J Nutr; 2010 Nov; 140(11):1901-6. PubMed ID: 20861217
[TBL] [Abstract][Full Text] [Related]
3. Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.
Yates KP; Deppe R; Comerford M; Masuoka H; Cummings OW; Tonascia J; Chalasani N; Vuppalanchi R;
PLoS One; 2017; 12(11):e0185813. PubMed ID: 29095942
[TBL] [Abstract][Full Text] [Related]
4. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
McDonald MG; Rieder MJ; Nakano M; Hsia CK; Rettie AE
Mol Pharmacol; 2009 Jun; 75(6):1337-46. PubMed ID: 19297519
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).
Bartolini D; Torquato P; Barola C; Russo A; Rychlicki C; Giusepponi D; Bellezza G; Sidoni A; Galarini R; Svegliati-Baroni G; Galli F
J Nutr Biochem; 2017 Sep; 47():120-131. PubMed ID: 28628909
[TBL] [Abstract][Full Text] [Related]
6. Computational analysis of missense variant CYP4F2*3 (V433M) in association with human CYP4F2 dysfunction: a functional and structural impact.
Farajzadeh-Dehkordi M; Mafakher L; Samiee-Rad F; Rahmani B
BMC Mol Cell Biol; 2023 May; 24(1):17. PubMed ID: 37161313
[TBL] [Abstract][Full Text] [Related]
7. The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes.
Fava C; Montagnana M; Danese E; Sjögren M; Almgren P; Guidi GC; Hedblad B; Engström G; Minuz P; Melander O
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):31-6. PubMed ID: 22484021
[TBL] [Abstract][Full Text] [Related]
8. The frequency of cytochrome 4F2 rs2108622 genetic variant and its effects on the lipid profile and complications of type II diabetes among a sample of patients in Jordan: A pilot study.
Jarrar Y; Alkhalili M; Alhawari H; Abaalkhail SJ; Alkhalili S; Alhawari H; Momani M; Obeidat AN; Fram RK
Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106715. PubMed ID: 36758722
[TBL] [Abstract][Full Text] [Related]
9. Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.
Bejarano-Achache I; Levy L; Mlynarsky L; Bialer M; Muszkat M; Caraco Y
Clin Ther; 2012 Apr; 34(4):811-23. PubMed ID: 22417713
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E and nonalcoholic fatty liver disease.
Pacana T; Sanyal AJ
Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):641-8. PubMed ID: 23075940
[TBL] [Abstract][Full Text] [Related]
11. Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.
Corey KE; Wilson LA; Altinbas A; Yates KP; Kleiner DE; Chung RT; Krauss RM; Chalasani N;
Aliment Pharmacol Ther; 2019 May; 49(9):1205-1213. PubMed ID: 30854694
[TBL] [Abstract][Full Text] [Related]
12. ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol.
Farley SM; Leonard SW; Taylor AW; Birringer M; Edson KZ; Rettie AE; Traber MG
Mol Nutr Food Res; 2013 Oct; 57(10):1785-93. PubMed ID: 23650179
[TBL] [Abstract][Full Text] [Related]
13. CYP4F2 genetic variant alters required warfarin dose.
Caldwell MD; Awad T; Johnson JA; Gage BF; Falkowski M; Gardina P; Hubbard J; Turpaz Y; Langaee TY; Eby C; King CR; Brower A; Schmelzer JR; Glurich I; Vidaillet HJ; Yale SH; Qi Zhang K; Berg RL; Burmester JK
Blood; 2008 Apr; 111(8):4106-12. PubMed ID: 18250228
[TBL] [Abstract][Full Text] [Related]
14. Interethnic variability of CYP4F2 (V433M) in admixed population of Roma and Hungarians.
Sipeky C; Weber A; Melegh BI; Matyas P; Janicsek I; Szalai R; Szabo I; Varnai R; Tarlos G; Ganczer A; Melegh B
Environ Toxicol Pharmacol; 2015 Jul; 40(1):280-3. PubMed ID: 26176903
[TBL] [Abstract][Full Text] [Related]
15. CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population.
Yu C; Yan Q; Fu C; Shi W; Wang H; Zeng C; Wang X
Lipids Health Dis; 2014 May; 13():83. PubMed ID: 24886380
[TBL] [Abstract][Full Text] [Related]
16. Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese.
Hu BC; Li Y; Li FH; Zhang Y; Sheng CS; Fan HQ; Wang JG
J Hypertens; 2011 Mar; 29(3):501-8. PubMed ID: 21150635
[TBL] [Abstract][Full Text] [Related]
17. Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke.
Munshi A; Sharma V; Kaul S; Al-Hazzani A; Alshatwi AA; Shafi G; Koppula R; Mallemoggala SB; Jyothy A
Mol Biol Rep; 2012 Feb; 39(2):1677-82. PubMed ID: 21625857
[TBL] [Abstract][Full Text] [Related]
18. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.
Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA;
Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292
[TBL] [Abstract][Full Text] [Related]
19. α-Tocopherol status and altered expression of α-tocopherol-related proteins in streptozotocin-induced type 1 diabetes in rat models.
Takitani K; Inoue K; Koh M; Miyazaki H; Kishi K; Inoue A; Tamai H
J Nutr Sci Vitaminol (Tokyo); 2014; 60(6):380-6. PubMed ID: 25866300
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphism in human CYP4F2 decreases 20-HETE production.
Stec DE; Roman RJ; Flasch A; Rieder MJ
Physiol Genomics; 2007 Jun; 30(1):74-81. PubMed ID: 17341693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
